Brief: GeNeuro H1 Operating Loss Narrows To 3.5 Million Euros

Geneuro SA

29/09/2021 19:26

Sept 29 (Reuters) - Geneuro SA  GNRO.PA :
    * GENEURO REPORTS 2021 HALF-YEAR RESULTS AND PROVIDES
CORPORATE
UPDATE
    * H1 OPERATING LOSS EUR 3.5 MILLION VERSUS LOSS EUR 3.7
MILLION
YEAR AGO
    * CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 3.0M AT 30 JUNE
2021
COMPARED TO EUR 6.8M AT 31 DECEMBER 2020
    * COMPANY RECORDED A NET LOSS DOWN 15% TO EUR 3.4M IN H1
2021,
COMPARED TO A NET LOSS OF EUR 3.9M IN H1 2020
    * GENERAL AND ADMINISTRATIVE EXPENSES DECREASED BY 17% IN H1
2021,
TOTALLED EUR 1.4M COMPARED TO EUR 1.7M IN COMPARABLE PERIOD
    * PROTECT-MS CLINICAL TRIAL RESULTS EXPECTED IN Q1 2022
    * COMPANY'S CASH PROVIDES FINANCIAL VISIBILITY UNTIL END OF
2022
AND PROVIDES SUFFICIENT TIME FOR STRATEGIC DISCUSSIONS FOLLOWING
RESULTS OF PROTECT-MS CLINICAL TRIAL OF TEMELIMAB IN MS

Source text for Eikon:  ID:nBw2k8jmpa 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))